News

Medigene participates at four conferences in October

SHOW RELEASE

Medigene participates at further conferences in September

SHOW RELEASE

Medigene announces inclusion in SDAX

SHOW RELEASE

Medigene announces change in executive leadership team

SHOW RELEASE

Medigene and Structured Immunity announce collaboration aimed at improving T Cell receptor development

SHOW RELEASE

Medigene Reports Results for the First Half of 2018

SHOW RELEASE

Medigene presents at upcoming conferences

SHOW RELEASE

Medigene CEO Dolores Schendel Receives Bavarian Order of Merit

SHOW RELEASE

Medigene presents at five upcoming conferences

SHOW RELEASE

Medigene successfully raises EUR 32.3 million in oversubscribed private placement

SHOW RELEASE

Medigene announces capital increase to fund immunotherapy programs

SHOW RELEASE

Medigene reports outcome of Annual General Meeting

SHOW RELEASE

Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy

SHOW RELEASE

Medigene AG reports First Quarter 2018 financials and provides operational update

SHOW RELEASE

Medigene's Academic Partners Provide Update on Planned MAGE-A1-specific TCR Clinical IIT during CIMT

SHOW RELEASE